Clinical-serological phenotypes map to distinct pulmonary patterns and outcomes in Sjögren disease-associated interstitial lung disease: a multicentre cluster analysis from the ISLAND and GRISS Study Groups of the Italian Society of Rheumatology
Frontiers in Immunology · 20.11.2026 · 17
DOI: 10.3389/fimmu.2026.1998253 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Immunology, online erschienen am 20.11.2026. Verfasst von Gaetano La Rocca und 30 weiteren Autor:innen. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Sjögren disease-associated interstitial lung disease (SjD-ILD) is heterogeneous in pulmonary morphology and clinical course. We investigated whether clinical-serological phenotypes of SjD were associated with distinct pulmonary expressions and outcomes.
Methods
This retrospective multicentre study included patients with primary SjD and HRCT-confirmed ILD from 13 Italian centres within the ISLAND and GRISS networks. Unsupervised TwoStep clustering used five prespecified variables selected a priori on clinical and biological grounds to capture key dimensions of the disease: age at SjD diagnosis, triple anti-Ro60/Ro52/La positivity, rheumatoid factor positivity, hypergammaglobulinaemia and recurrent salivary gland swelling. Pulmonary variables, treatment and outcomes were excluded from clustering and analysed as external correlates. Clinically significant ILD deterioration was defined as absolute FVC decline ≥10 percentage points and/or new requirement for long-term oxygen therapy, lung transplantation or ILD-related death.
Results
Among 140 patients, mean ILD follow-up was 4.9 years. Clustering included 133 patients and identified two balanced clinical-serological phenotypes. Cluster 1 (n=67) was characterised by older age at SjD diagnosis (67.6 vs 57.4 years; p<0.001) and less prominent conventional B-cell-related features. Cluster 2 (n=66) showed enrichment in hypergammaglobulinaemia (81.8% vs 0%; p<0.001), triple anti-Ro60/Ro52/La positivity (50.0% vs 0%; p<0.001), low C4 (22.7% vs 3.0%; p<0.001), lymphadenopathy (27.3% vs 9.0%; p=0.006), haematological involvement (25.8% vs 4.5%; p<0.001) and lymphopenia (21.5% vs 9.1%; p=0.048). ILD was diagnosed before or within 3 months of SjD diagnosis more often in Cluster 1 (73.1% vs 43.9%; p<0.001), with greater smoking exposure (48.4% vs 25.0%; p=0.006) and more frequent UIP (25.4% vs 11.5%; p=0.046), whereas LIP was enriched in Cluster 2 (32.8% vs 6.8%; p<0.001). Clinically significant ILD deterioration was assessable in 110 patients and more frequent in Cluster 1 (49.1% vs 26.9%; p=0.020), as were hard ILD-related endpoints (20.9% vs 7.6%; p=0.028). UIP remained independently associated with deterioration (OR 6.29, 95% CI 1.68–23.56; p=0.006), while the cluster association was attenuated after adjustment for pulmonary morphology and clinical covariates.
Conclusions
Clinical-serological phenotypes of SjD were associated with distinct pulmonary expressions and outcomes in SjD-ILD. Integrating SjD phenotyping with pulmonary characteristics may improve patient stratification and inform future biological and treatment-response studies.
Zitieren
APA
Rocca, G. L., Ferro, F., Manfredi, A., Faggiano, A., Santoro, F., Guiducci, S., Cometi, L., Lepri, G., Corrado, A., Rotondo, C., Barile, R., Berardino, M. D., Nicchi, M., Cozzini, F., Burattini, C., Conigliaro, P., Cela, E., Dagna, L., Gallina, G., …, & Baldini, C. (2026). Clinical-serological phenotypes map to distinct pulmonary patterns and outcomes in Sjögren disease-associated interstitial lung disease: a multicentre cluster analysis from the ISLAND and GRISS Study Groups of the Italian Society of Rheumatology. Frontiers in Immunology, 17. https://doi.org/10.3389/fimmu.2026.1998253
Vancouver
Rocca GL, Ferro F, Manfredi A, Faggiano A, Santoro F, Guiducci S, et al. Clinical-serological phenotypes map to distinct pulmonary patterns and outcomes in Sjögren disease-associated interstitial lung disease: a multicentre cluster analysis from the ISLAND and GRISS Study Groups of the Italian Society of Rheumatology. Frontiers in Immunology. 2026;17. doi:10.3389/fimmu.2026.1998253
BibTeX
@article{Rocca2026,
author = {Rocca, Gaetano La and Ferro, Francesco and Manfredi, Andreina and Faggiano, Andrea and Santoro, Filippo and Guiducci, Serena and Cometi, Laura and Lepri, Gemma and Corrado, Addolorata and Rotondo, Cinzia and Barile, Raffaele and Berardino, Marta Di and Nicchi, Martina and Cozzini, Francesca and Burattini, Cecilia and Conigliaro, Paola and Cela, Eneida and Dagna, Lorenzo and Gallina, Gabriele and Berardicurti, Onorina and Marino, Annalisa and Monaco, Andrea Lo and Ruffilli, Francesca and Faggioli, Paola and Capparelli, Eugenio and Favero, Marta and Fassio, Angelo and Mosca, Marta and Sebastiani, Marco and Bartoloni, Elena and Baldini, Chiara},
title = {Clinical-serological phenotypes map to distinct pulmonary patterns and outcomes in Sjögren disease-associated interstitial lung disease: a multicentre cluster analysis from the ISLAND and GRISS Study Groups of the Italian Society of Rheumatology},
journal = {Frontiers in Immunology},
year = {2026},
volume = {17},
doi = {10.3389/fimmu.2026.1998253}
}
EUVIMED